AI assistant
Sending…
MBX Biosciences, Inc. — Director's Dealing 2024
Sep 13, 2024
32409_dirs_2024-09-13_367dbb97-56ad-425e-9b42-9569b09edcd1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MBX Biosciences, Inc. (MBX)
CIK: 0001776111
Period of Report: 2024-09-12
Reporting Person: Pescovitz Ora H. (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-09-12 | Stock Option (Right to Buy) | $16.00 | A | 15963 | Acquired | 2034-09-11 | Common Stock (15963) | Direct |
Footnotes
F1: 25% of the shares underlying this option vest and become exercisable on September 12, 2025, with the remaining 75% vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
More from MBX Biosciences, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 5
Regulatory Filings
2026
May 11
Earnings Release
2026
May 7
Interim / Quarterly Report
2026
May 7
Annual Report
2026
Apr 22
Proxy Solicitation & Information Statement
2026
Apr 22
Regulatory Filings
2026
Mar 25
Director's Dealing
2026
Feb 27
Board/Management Information
2026
Feb 27
Major Shareholding Notification
2026
Feb 11